s********s
发帖数: 579 | 1 AZ's 30% of it R&D workforce (10600 in total) will be axed. 1 US site might
go. | l****y
发帖数: 64 | 2 AstraZeneca PLC said it would continue cutting jobs by eliminating another
10,400 by 2014, or about 16% of its work force, including thousands in its
research-and-development group, which is to be reorganized.
The overhaul will divide researchers into eight groups, each focused on a
different disease area, and will fund each group "based on performance,"
AstraZeneca officials said Thursday, suggesting that funding could be
withdrawn if results are poor.
About 3,500 R&D jobs will be cut in the pr | w******y
发帖数: 8040 | 3 又一波血雨腥风
【在 l****y 的大作中提到】
: AstraZeneca PLC said it would continue cutting jobs by eliminating another
: 10,400 by 2014, or about 16% of its work force, including thousands in its
: research-and-development group, which is to be reorganized.
: The overhaul will divide researchers into eight groups, each focused on a
: different disease area, and will fund each group "based on performance,"
: AstraZeneca officials said Thursday, suggesting that funding could be
: withdrawn if results are poor.
: About 3,500 R&D jobs will be cut in the pr
| i***R
发帖数: 663 | 4 纯属瞎扯： 大药厂最终将成为天使投资基金，而小公司或许将雨后春笋般涌现。
学术界将承担更多横向研发课题，老板会有更多机会组建小公司。
大药厂研发，人浮于事的癌症是很难纠正的。半学半商可能还比较有前途。 | s********s
发帖数: 579 | 5 Agree, Big pharma很有可能发展成为如VC or PE专门买入小Bio,pharma然后包装推向
市场，用强大的Sales赚钱。 | h*******o
发帖数: 4884 | 6 大药厂是不可能成为Angels最多就是VC
【在 i***R 的大作中提到】
: 纯属瞎扯： 大药厂最终将成为天使投资基金，而小公司或许将雨后春笋般涌现。
: 学术界将承担更多横向研发课题，老板会有更多机会组建小公司。
: 大药厂研发，人浮于事的癌症是很难纠正的。半学半商可能还比较有前途。
| i***R
发帖数: 663 | 7 写错了， 应该是VC
【在 h*******o 的大作中提到】
: 大药厂是不可能成为Angels最多就是VC
|
|
